Global Needle-free Injection Systems
Global Needle-free Injection Systems

Needle-free Injection Systems Comprehensive Study by Type (Fillable Needle-Free Injector, Prefilled Needle-Free Injector), Application (Hospitals, Clinics, Ambulatory Surgical Centers, Others), Technology (Jet-Based Needle-Free Injectors, Spring-Based Needle-Free Injectors, Laser-Powered Needle-Free Injectors, Vibration-Based Needle-Free Injectors), Medication (Liquid-based needle-free injectors, Powder-based needle-free injectors, Projectile/depot-based needle-free injectors), Usability (Reusable Needle-Free Injectors, Disposable Needle-Free Injectors), Site of Delivery (Intradermal injectors, Intramuscular injectors, Subcutaneous injectors), End User (Hospitals and Clinics, Homecare Settings, Research Laboratories, Pharmaceutical and Biotechnology companies, End Users) Players and Region - Global Market Outlook to 2025

Needle-free Injection Systems Market Segmented into XX Submarkets. | Forecast Years: 2020- 2025  

Oct 2020 Edition 210 Pages 200 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
What is Needle-free Injection Systems Market?

The needle-free injection system is to bring the different drugs into patients without penetrating the skin with an ordinary needle. Without the needle, innovation offers the many advantages of decreasing patients worry about the utilization of needle. Needle-free Injection is the compelling Injection a wide scope of medications and bioequivalent to needle and needle. It brings about less torment and is firmly favored by patients. Extra advantages incorporate quick infusion contrasted and regular needles and no needle removal issues. Not just the advantage of the drug business to the expanding item deals, it has the additional possibility to build consistency with dose regimens and improved results. Today, they are consistently creating innovation that vows to make the organization of medication more proficient and less agonizing.

The market study is being classified by Type (Fillable Needle-Free Injector and Prefilled Needle-Free Injector), by Application (Hospitals, Clinics, Ambulatory Surgical Centers and Others) and major geographies with country level break-up.

BD Medical (United States), Medtronic(United States), Smiths Medical (United States), Antares Pharma Inc(United States), Endo International(Ireland), Pharma Jet (Netherlands), Bioject Medical Technologies (United States), Terumo Corporation(Japan), Medical International Technology(Canada) and Injex Pharama Ag (Germany) are some of the key players profiled in the study.

The companies are now exploring the market by adopting mergers & acquisitions, expansions, investments, new developments in existing products, and collaborations as their preferred strategies. The players are also exploring new geographies and industries through expansions and acquisitions so as to avail a competitive advantage through combined synergies. Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Needle-free Injection Systems market throughout the predicted period.

Segment Analysis
Analyst at AMA have segmented the market study of Global Needle-free Injection Systems market by Type, Application and Region.

On the basis of geography, the market of Needle-free Injection Systems has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Market Drivers
  • The rise in Demand for Self-Injection Devices
  • Growing Prevalence of Chronic Diseases


Restraints
  • Higher Cost of Development as Compared to Conventional Injection System

Opportunities
  • Rising Demand for Biosimilars and Vaccination

Challenges
  • Need to Ensure System Sterility





Key Target Audience
New Entrants/Investors, Analysts and Strategic Business Planners, Needle-free Injection Systems Manufacturer, Raw Material Suppliers, Dealers, Suppliers, Traders, and Distributors, Venture Capitalists and Private Equity Firms, Government Regulatory and Research Organizations and End-Use Industry

Customization in the Report Available:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase
Report Objectives / Segmentation Covered
By Type
  • Fillable Needle-Free Injector
  • Prefilled Needle-Free Injector
By Application
  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers
  • Others
By Technology
  • Jet-Based Needle-Free Injectors
  • Spring-Based Needle-Free Injectors
  • Laser-Powered Needle-Free Injectors
  • Vibration-Based Needle-Free Injectors

By Medication
  • Liquid-based needle-free injectors
  • Powder-based needle-free injectors
  • Projectile/depot-based needle-free injectors

By Usability
  • Reusable Needle-Free Injectors
  • Disposable Needle-Free Injectors

By Site of Delivery
  • Intradermal injectors
  • Intramuscular injectors
  • Subcutaneous injectors

By End User
  • Hospitals and Clinics
  • Homecare Settings
  • Research Laboratories
  • Pharmaceutical and Biotechnology companies
  • End Users

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. The rise in Demand for Self-Injection Devices
      • 3.2.2. Growing Prevalence of Chronic Diseases
    • 3.3. Market Challenges
      • 3.3.1. Need to Ensure System Sterility
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Needle-free Injection Systems, by Type, Application, Technology, Medication, Usability, Site of Delivery, End User and Region (value, volume and price ) (2014-2019)
    • 5.1. Introduction
    • 5.2. Global Needle-free Injection Systems (Value)
      • 5.2.1. Global Needle-free Injection Systems by: Type (Value)
        • 5.2.1.1. Fillable Needle-Free Injector
        • 5.2.1.2. Prefilled Needle-Free Injector
      • 5.2.2. Global Needle-free Injection Systems by: Application (Value)
        • 5.2.2.1. Hospitals
        • 5.2.2.2. Clinics
        • 5.2.2.3. Ambulatory Surgical Centers
        • 5.2.2.4. Others
      • 5.2.3. Global Needle-free Injection Systems by: Technology (Value)
        • 5.2.3.1. Jet-Based Needle-Free Injectors
        • 5.2.3.2. Spring-Based Needle-Free Injectors
        • 5.2.3.3. Laser-Powered Needle-Free Injectors
        • 5.2.3.4. Vibration-Based Needle-Free Injectors
      • 5.2.4. Global Needle-free Injection Systems by: Medication (Value)
        • 5.2.4.1. Liquid-based needle-free injectors
        • 5.2.4.2. Powder-based needle-free injectors
        • 5.2.4.3. Projectile/depot-based needle-free injectors
      • 5.2.5. Global Needle-free Injection Systems by: Usability (Value)
        • 5.2.5.1. Reusable Needle-Free Injectors
        • 5.2.5.2. Disposable Needle-Free Injectors
      • 5.2.6. Global Needle-free Injection Systems by: Site of Delivery (Value)
        • 5.2.6.1. Intradermal injectors
        • 5.2.6.2. Intramuscular injectors
        • 5.2.6.3. Subcutaneous injectors
      • 5.2.7. Global Needle-free Injection Systems by: End User (Value)
        • 5.2.7.1. Hospitals and Clinics
        • 5.2.7.2. Homecare Settings
        • 5.2.7.3. Research Laboratories
        • 5.2.7.4. Pharmaceutical and Biotechnology companies
        • 5.2.7.5. End Users
      • 5.2.8. Global Needle-free Injection Systems Region
        • 5.2.8.1. South America
          • 5.2.8.1.1. Brazil
          • 5.2.8.1.2. Argentina
          • 5.2.8.1.3. Rest of South America
        • 5.2.8.2. Asia Pacific
          • 5.2.8.2.1. China
          • 5.2.8.2.2. Japan
          • 5.2.8.2.3. India
          • 5.2.8.2.4. South Korea
          • 5.2.8.2.5. Taiwan
          • 5.2.8.2.6. Australia
          • 5.2.8.2.7. Rest of Asia-Pacific
        • 5.2.8.3. Europe
          • 5.2.8.3.1. Germany
          • 5.2.8.3.2. France
          • 5.2.8.3.3. Italy
          • 5.2.8.3.4. United Kingdom
          • 5.2.8.3.5. Netherlands
          • 5.2.8.3.6. Rest of Europe
        • 5.2.8.4. MEA
          • 5.2.8.4.1. Middle East
          • 5.2.8.4.2. Africa
        • 5.2.8.5. North America
          • 5.2.8.5.1. United States
          • 5.2.8.5.2. Canada
          • 5.2.8.5.3. Mexico
    • 5.3. Global Needle-free Injection Systems (Volume)
      • 5.3.1. Global Needle-free Injection Systems by: Type (Volume)
        • 5.3.1.1. Fillable Needle-Free Injector
        • 5.3.1.2. Prefilled Needle-Free Injector
      • 5.3.2. Global Needle-free Injection Systems by: Application (Volume)
        • 5.3.2.1. Hospitals
        • 5.3.2.2. Clinics
        • 5.3.2.3. Ambulatory Surgical Centers
        • 5.3.2.4. Others
      • 5.3.3. Global Needle-free Injection Systems by: Technology (Volume)
        • 5.3.3.1. Jet-Based Needle-Free Injectors
        • 5.3.3.2. Spring-Based Needle-Free Injectors
        • 5.3.3.3. Laser-Powered Needle-Free Injectors
        • 5.3.3.4. Vibration-Based Needle-Free Injectors
      • 5.3.4. Global Needle-free Injection Systems by: Medication (Volume)
        • 5.3.4.1. Liquid-based needle-free injectors
        • 5.3.4.2. Powder-based needle-free injectors
        • 5.3.4.3. Projectile/depot-based needle-free injectors
      • 5.3.5. Global Needle-free Injection Systems by: Usability (Volume)
        • 5.3.5.1. Reusable Needle-Free Injectors
        • 5.3.5.2. Disposable Needle-Free Injectors
      • 5.3.6. Global Needle-free Injection Systems by: Site of Delivery (Volume)
        • 5.3.6.1. Intradermal injectors
        • 5.3.6.2. Intramuscular injectors
        • 5.3.6.3. Subcutaneous injectors
      • 5.3.7. Global Needle-free Injection Systems by: End User (Volume)
        • 5.3.7.1. Hospitals and Clinics
        • 5.3.7.2. Homecare Settings
        • 5.3.7.3. Research Laboratories
        • 5.3.7.4. Pharmaceutical and Biotechnology companies
        • 5.3.7.5. End Users
      • 5.3.8. Global Needle-free Injection Systems Region
        • 5.3.8.1. South America
          • 5.3.8.1.1. Brazil
          • 5.3.8.1.2. Argentina
          • 5.3.8.1.3. Rest of South America
        • 5.3.8.2. Asia Pacific
          • 5.3.8.2.1. China
          • 5.3.8.2.2. Japan
          • 5.3.8.2.3. India
          • 5.3.8.2.4. South Korea
          • 5.3.8.2.5. Taiwan
          • 5.3.8.2.6. Australia
          • 5.3.8.2.7. Rest of Asia-Pacific
        • 5.3.8.3. Europe
          • 5.3.8.3.1. Germany
          • 5.3.8.3.2. France
          • 5.3.8.3.3. Italy
          • 5.3.8.3.4. United Kingdom
          • 5.3.8.3.5. Netherlands
          • 5.3.8.3.6. Rest of Europe
        • 5.3.8.4. MEA
          • 5.3.8.4.1. Middle East
          • 5.3.8.4.2. Africa
        • 5.3.8.5. North America
          • 5.3.8.5.1. United States
          • 5.3.8.5.2. Canada
          • 5.3.8.5.3. Mexico
    • 5.4. Global Needle-free Injection Systems (Price)
      • 5.4.1. Global Needle-free Injection Systems by: Type (Price)
  • 6. Needle-free Injection Systems: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2019)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. BD Medical (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Medtronic(United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Smiths Medical (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Antares Pharma Inc(United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Endo International(Ireland)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Pharma Jet (Netherlands)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Bioject Medical Technologies (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Terumo Corporation(Japan)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Medical International Technology(Canada)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Injex Pharama Ag (Germany)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Needle-free Injection Systems Sale, by Type, Application, Technology, Medication, Usability, Site of Delivery, End User and Region (value, volume and price ) (2020-2025)
    • 7.1. Introduction
    • 7.2. Global Needle-free Injection Systems (Value)
      • 7.2.1. Global Needle-free Injection Systems by: Type (Value)
        • 7.2.1.1. Fillable Needle-Free Injector
        • 7.2.1.2. Prefilled Needle-Free Injector
      • 7.2.2. Global Needle-free Injection Systems by: Application (Value)
        • 7.2.2.1. Hospitals
        • 7.2.2.2. Clinics
        • 7.2.2.3. Ambulatory Surgical Centers
        • 7.2.2.4. Others
      • 7.2.3. Global Needle-free Injection Systems by: Technology (Value)
        • 7.2.3.1. Jet-Based Needle-Free Injectors
        • 7.2.3.2. Spring-Based Needle-Free Injectors
        • 7.2.3.3. Laser-Powered Needle-Free Injectors
        • 7.2.3.4. Vibration-Based Needle-Free Injectors
      • 7.2.4. Global Needle-free Injection Systems by: Medication (Value)
        • 7.2.4.1. Liquid-based needle-free injectors
        • 7.2.4.2. Powder-based needle-free injectors
        • 7.2.4.3. Projectile/depot-based needle-free injectors
      • 7.2.5. Global Needle-free Injection Systems by: Usability (Value)
        • 7.2.5.1. Reusable Needle-Free Injectors
        • 7.2.5.2. Disposable Needle-Free Injectors
      • 7.2.6. Global Needle-free Injection Systems by: Site of Delivery (Value)
        • 7.2.6.1. Intradermal injectors
        • 7.2.6.2. Intramuscular injectors
        • 7.2.6.3. Subcutaneous injectors
      • 7.2.7. Global Needle-free Injection Systems by: End User (Value)
        • 7.2.7.1. Hospitals and Clinics
        • 7.2.7.2. Homecare Settings
        • 7.2.7.3. Research Laboratories
        • 7.2.7.4. Pharmaceutical and Biotechnology companies
        • 7.2.7.5. End Users
      • 7.2.8. Global Needle-free Injection Systems Region
        • 7.2.8.1. South America
          • 7.2.8.1.1. Brazil
          • 7.2.8.1.2. Argentina
          • 7.2.8.1.3. Rest of South America
        • 7.2.8.2. Asia Pacific
          • 7.2.8.2.1. China
          • 7.2.8.2.2. Japan
          • 7.2.8.2.3. India
          • 7.2.8.2.4. South Korea
          • 7.2.8.2.5. Taiwan
          • 7.2.8.2.6. Australia
          • 7.2.8.2.7. Rest of Asia-Pacific
        • 7.2.8.3. Europe
          • 7.2.8.3.1. Germany
          • 7.2.8.3.2. France
          • 7.2.8.3.3. Italy
          • 7.2.8.3.4. United Kingdom
          • 7.2.8.3.5. Netherlands
          • 7.2.8.3.6. Rest of Europe
        • 7.2.8.4. MEA
          • 7.2.8.4.1. Middle East
          • 7.2.8.4.2. Africa
        • 7.2.8.5. North America
          • 7.2.8.5.1. United States
          • 7.2.8.5.2. Canada
          • 7.2.8.5.3. Mexico
    • 7.3. Global Needle-free Injection Systems (Volume)
      • 7.3.1. Global Needle-free Injection Systems by: Type (Volume)
        • 7.3.1.1. Fillable Needle-Free Injector
        • 7.3.1.2. Prefilled Needle-Free Injector
      • 7.3.2. Global Needle-free Injection Systems by: Application (Volume)
        • 7.3.2.1. Hospitals
        • 7.3.2.2. Clinics
        • 7.3.2.3. Ambulatory Surgical Centers
        • 7.3.2.4. Others
      • 7.3.3. Global Needle-free Injection Systems by: Technology (Volume)
        • 7.3.3.1. Jet-Based Needle-Free Injectors
        • 7.3.3.2. Spring-Based Needle-Free Injectors
        • 7.3.3.3. Laser-Powered Needle-Free Injectors
        • 7.3.3.4. Vibration-Based Needle-Free Injectors
      • 7.3.4. Global Needle-free Injection Systems by: Medication (Volume)
        • 7.3.4.1. Liquid-based needle-free injectors
        • 7.3.4.2. Powder-based needle-free injectors
        • 7.3.4.3. Projectile/depot-based needle-free injectors
      • 7.3.5. Global Needle-free Injection Systems by: Usability (Volume)
        • 7.3.5.1. Reusable Needle-Free Injectors
        • 7.3.5.2. Disposable Needle-Free Injectors
      • 7.3.6. Global Needle-free Injection Systems by: Site of Delivery (Volume)
        • 7.3.6.1. Intradermal injectors
        • 7.3.6.2. Intramuscular injectors
        • 7.3.6.3. Subcutaneous injectors
      • 7.3.7. Global Needle-free Injection Systems by: End User (Volume)
        • 7.3.7.1. Hospitals and Clinics
        • 7.3.7.2. Homecare Settings
        • 7.3.7.3. Research Laboratories
        • 7.3.7.4. Pharmaceutical and Biotechnology companies
        • 7.3.7.5. End Users
      • 7.3.8. Global Needle-free Injection Systems Region
        • 7.3.8.1. South America
          • 7.3.8.1.1. Brazil
          • 7.3.8.1.2. Argentina
          • 7.3.8.1.3. Rest of South America
        • 7.3.8.2. Asia Pacific
          • 7.3.8.2.1. China
          • 7.3.8.2.2. Japan
          • 7.3.8.2.3. India
          • 7.3.8.2.4. South Korea
          • 7.3.8.2.5. Taiwan
          • 7.3.8.2.6. Australia
          • 7.3.8.2.7. Rest of Asia-Pacific
        • 7.3.8.3. Europe
          • 7.3.8.3.1. Germany
          • 7.3.8.3.2. France
          • 7.3.8.3.3. Italy
          • 7.3.8.3.4. United Kingdom
          • 7.3.8.3.5. Netherlands
          • 7.3.8.3.6. Rest of Europe
        • 7.3.8.4. MEA
          • 7.3.8.4.1. Middle East
          • 7.3.8.4.2. Africa
        • 7.3.8.5. North America
          • 7.3.8.5.1. United States
          • 7.3.8.5.2. Canada
          • 7.3.8.5.3. Mexico
    • 7.4. Global Needle-free Injection Systems (Price)
      • 7.4.1. Global Needle-free Injection Systems by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Needle-free Injection Systems: by Type(USD Million)
  • Table 2. Needle-free Injection Systems Fillable Needle-Free Injector , by Region USD Million (2014-2019)
  • Table 3. Needle-free Injection Systems Prefilled Needle-Free Injector , by Region USD Million (2014-2019)
  • Table 4. Needle-free Injection Systems: by Application(USD Million)
  • Table 5. Needle-free Injection Systems Hospitals , by Region USD Million (2014-2019)
  • Table 6. Needle-free Injection Systems Clinics , by Region USD Million (2014-2019)
  • Table 7. Needle-free Injection Systems Ambulatory Surgical Centers , by Region USD Million (2014-2019)
  • Table 8. Needle-free Injection Systems Others , by Region USD Million (2014-2019)
  • Table 9. Needle-free Injection Systems: by Technology(USD Million)
  • Table 10. Needle-free Injection Systems Jet-Based Needle-Free Injectors , by Region USD Million (2014-2019)
  • Table 11. Needle-free Injection Systems Spring-Based Needle-Free Injectors , by Region USD Million (2014-2019)
  • Table 12. Needle-free Injection Systems Laser-Powered Needle-Free Injectors , by Region USD Million (2014-2019)
  • Table 13. Needle-free Injection Systems Vibration-Based Needle-Free Injectors , by Region USD Million (2014-2019)
  • Table 14. Needle-free Injection Systems: by Medication(USD Million)
  • Table 15. Needle-free Injection Systems Liquid-based needle-free injectors , by Region USD Million (2014-2019)
  • Table 16. Needle-free Injection Systems Powder-based needle-free injectors , by Region USD Million (2014-2019)
  • Table 17. Needle-free Injection Systems Projectile/depot-based needle-free injectors , by Region USD Million (2014-2019)
  • Table 18. Needle-free Injection Systems: by Usability(USD Million)
  • Table 19. Needle-free Injection Systems Reusable Needle-Free Injectors , by Region USD Million (2014-2019)
  • Table 20. Needle-free Injection Systems Disposable Needle-Free Injectors , by Region USD Million (2014-2019)
  • Table 21. Needle-free Injection Systems: by Site of Delivery(USD Million)
  • Table 22. Needle-free Injection Systems Intradermal injectors , by Region USD Million (2014-2019)
  • Table 23. Needle-free Injection Systems Intramuscular injectors , by Region USD Million (2014-2019)
  • Table 24. Needle-free Injection Systems Subcutaneous injectors , by Region USD Million (2014-2019)
  • Table 25. Needle-free Injection Systems: by End User(USD Million)
  • Table 26. Needle-free Injection Systems Hospitals and Clinics , by Region USD Million (2014-2019)
  • Table 27. Needle-free Injection Systems Homecare Settings , by Region USD Million (2014-2019)
  • Table 28. Needle-free Injection Systems Research Laboratories , by Region USD Million (2014-2019)
  • Table 29. Needle-free Injection Systems Pharmaceutical and Biotechnology companies , by Region USD Million (2014-2019)
  • Table 30. Needle-free Injection Systems End Users , by Region USD Million (2014-2019)
  • Table 31. South America Needle-free Injection Systems, by Country USD Million (2014-2019)
  • Table 32. South America Needle-free Injection Systems, by Type USD Million (2014-2019)
  • Table 33. South America Needle-free Injection Systems, by Application USD Million (2014-2019)
  • Table 34. South America Needle-free Injection Systems, by Technology USD Million (2014-2019)
  • Table 35. South America Needle-free Injection Systems, by Medication USD Million (2014-2019)
  • Table 36. South America Needle-free Injection Systems, by Usability USD Million (2014-2019)
  • Table 37. South America Needle-free Injection Systems, by Site of Delivery USD Million (2014-2019)
  • Table 38. South America Needle-free Injection Systems, by End User USD Million (2014-2019)
  • Table 39. Brazil Needle-free Injection Systems, by Type USD Million (2014-2019)
  • Table 40. Brazil Needle-free Injection Systems, by Application USD Million (2014-2019)
  • Table 41. Brazil Needle-free Injection Systems, by Technology USD Million (2014-2019)
  • Table 42. Brazil Needle-free Injection Systems, by Medication USD Million (2014-2019)
  • Table 43. Brazil Needle-free Injection Systems, by Usability USD Million (2014-2019)
  • Table 44. Brazil Needle-free Injection Systems, by Site of Delivery USD Million (2014-2019)
  • Table 45. Brazil Needle-free Injection Systems, by End User USD Million (2014-2019)
  • Table 46. Argentina Needle-free Injection Systems, by Type USD Million (2014-2019)
  • Table 47. Argentina Needle-free Injection Systems, by Application USD Million (2014-2019)
  • Table 48. Argentina Needle-free Injection Systems, by Technology USD Million (2014-2019)
  • Table 49. Argentina Needle-free Injection Systems, by Medication USD Million (2014-2019)
  • Table 50. Argentina Needle-free Injection Systems, by Usability USD Million (2014-2019)
  • Table 51. Argentina Needle-free Injection Systems, by Site of Delivery USD Million (2014-2019)
  • Table 52. Argentina Needle-free Injection Systems, by End User USD Million (2014-2019)
  • Table 53. Rest of South America Needle-free Injection Systems, by Type USD Million (2014-2019)
  • Table 54. Rest of South America Needle-free Injection Systems, by Application USD Million (2014-2019)
  • Table 55. Rest of South America Needle-free Injection Systems, by Technology USD Million (2014-2019)
  • Table 56. Rest of South America Needle-free Injection Systems, by Medication USD Million (2014-2019)
  • Table 57. Rest of South America Needle-free Injection Systems, by Usability USD Million (2014-2019)
  • Table 58. Rest of South America Needle-free Injection Systems, by Site of Delivery USD Million (2014-2019)
  • Table 59. Rest of South America Needle-free Injection Systems, by End User USD Million (2014-2019)
  • Table 60. Asia Pacific Needle-free Injection Systems, by Country USD Million (2014-2019)
  • Table 61. Asia Pacific Needle-free Injection Systems, by Type USD Million (2014-2019)
  • Table 62. Asia Pacific Needle-free Injection Systems, by Application USD Million (2014-2019)
  • Table 63. Asia Pacific Needle-free Injection Systems, by Technology USD Million (2014-2019)
  • Table 64. Asia Pacific Needle-free Injection Systems, by Medication USD Million (2014-2019)
  • Table 65. Asia Pacific Needle-free Injection Systems, by Usability USD Million (2014-2019)
  • Table 66. Asia Pacific Needle-free Injection Systems, by Site of Delivery USD Million (2014-2019)
  • Table 67. Asia Pacific Needle-free Injection Systems, by End User USD Million (2014-2019)
  • Table 68. China Needle-free Injection Systems, by Type USD Million (2014-2019)
  • Table 69. China Needle-free Injection Systems, by Application USD Million (2014-2019)
  • Table 70. China Needle-free Injection Systems, by Technology USD Million (2014-2019)
  • Table 71. China Needle-free Injection Systems, by Medication USD Million (2014-2019)
  • Table 72. China Needle-free Injection Systems, by Usability USD Million (2014-2019)
  • Table 73. China Needle-free Injection Systems, by Site of Delivery USD Million (2014-2019)
  • Table 74. China Needle-free Injection Systems, by End User USD Million (2014-2019)
  • Table 75. Japan Needle-free Injection Systems, by Type USD Million (2014-2019)
  • Table 76. Japan Needle-free Injection Systems, by Application USD Million (2014-2019)
  • Table 77. Japan Needle-free Injection Systems, by Technology USD Million (2014-2019)
  • Table 78. Japan Needle-free Injection Systems, by Medication USD Million (2014-2019)
  • Table 79. Japan Needle-free Injection Systems, by Usability USD Million (2014-2019)
  • Table 80. Japan Needle-free Injection Systems, by Site of Delivery USD Million (2014-2019)
  • Table 81. Japan Needle-free Injection Systems, by End User USD Million (2014-2019)
  • Table 82. India Needle-free Injection Systems, by Type USD Million (2014-2019)
  • Table 83. India Needle-free Injection Systems, by Application USD Million (2014-2019)
  • Table 84. India Needle-free Injection Systems, by Technology USD Million (2014-2019)
  • Table 85. India Needle-free Injection Systems, by Medication USD Million (2014-2019)
  • Table 86. India Needle-free Injection Systems, by Usability USD Million (2014-2019)
  • Table 87. India Needle-free Injection Systems, by Site of Delivery USD Million (2014-2019)
  • Table 88. India Needle-free Injection Systems, by End User USD Million (2014-2019)
  • Table 89. South Korea Needle-free Injection Systems, by Type USD Million (2014-2019)
  • Table 90. South Korea Needle-free Injection Systems, by Application USD Million (2014-2019)
  • Table 91. South Korea Needle-free Injection Systems, by Technology USD Million (2014-2019)
  • Table 92. South Korea Needle-free Injection Systems, by Medication USD Million (2014-2019)
  • Table 93. South Korea Needle-free Injection Systems, by Usability USD Million (2014-2019)
  • Table 94. South Korea Needle-free Injection Systems, by Site of Delivery USD Million (2014-2019)
  • Table 95. South Korea Needle-free Injection Systems, by End User USD Million (2014-2019)
  • Table 96. Taiwan Needle-free Injection Systems, by Type USD Million (2014-2019)
  • Table 97. Taiwan Needle-free Injection Systems, by Application USD Million (2014-2019)
  • Table 98. Taiwan Needle-free Injection Systems, by Technology USD Million (2014-2019)
  • Table 99. Taiwan Needle-free Injection Systems, by Medication USD Million (2014-2019)
  • Table 100. Taiwan Needle-free Injection Systems, by Usability USD Million (2014-2019)
  • Table 101. Taiwan Needle-free Injection Systems, by Site of Delivery USD Million (2014-2019)
  • Table 102. Taiwan Needle-free Injection Systems, by End User USD Million (2014-2019)
  • Table 103. Australia Needle-free Injection Systems, by Type USD Million (2014-2019)
  • Table 104. Australia Needle-free Injection Systems, by Application USD Million (2014-2019)
  • Table 105. Australia Needle-free Injection Systems, by Technology USD Million (2014-2019)
  • Table 106. Australia Needle-free Injection Systems, by Medication USD Million (2014-2019)
  • Table 107. Australia Needle-free Injection Systems, by Usability USD Million (2014-2019)
  • Table 108. Australia Needle-free Injection Systems, by Site of Delivery USD Million (2014-2019)
  • Table 109. Australia Needle-free Injection Systems, by End User USD Million (2014-2019)
  • Table 110. Rest of Asia-Pacific Needle-free Injection Systems, by Type USD Million (2014-2019)
  • Table 111. Rest of Asia-Pacific Needle-free Injection Systems, by Application USD Million (2014-2019)
  • Table 112. Rest of Asia-Pacific Needle-free Injection Systems, by Technology USD Million (2014-2019)
  • Table 113. Rest of Asia-Pacific Needle-free Injection Systems, by Medication USD Million (2014-2019)
  • Table 114. Rest of Asia-Pacific Needle-free Injection Systems, by Usability USD Million (2014-2019)
  • Table 115. Rest of Asia-Pacific Needle-free Injection Systems, by Site of Delivery USD Million (2014-2019)
  • Table 116. Rest of Asia-Pacific Needle-free Injection Systems, by End User USD Million (2014-2019)
  • Table 117. Europe Needle-free Injection Systems, by Country USD Million (2014-2019)
  • Table 118. Europe Needle-free Injection Systems, by Type USD Million (2014-2019)
  • Table 119. Europe Needle-free Injection Systems, by Application USD Million (2014-2019)
  • Table 120. Europe Needle-free Injection Systems, by Technology USD Million (2014-2019)
  • Table 121. Europe Needle-free Injection Systems, by Medication USD Million (2014-2019)
  • Table 122. Europe Needle-free Injection Systems, by Usability USD Million (2014-2019)
  • Table 123. Europe Needle-free Injection Systems, by Site of Delivery USD Million (2014-2019)
  • Table 124. Europe Needle-free Injection Systems, by End User USD Million (2014-2019)
  • Table 125. Germany Needle-free Injection Systems, by Type USD Million (2014-2019)
  • Table 126. Germany Needle-free Injection Systems, by Application USD Million (2014-2019)
  • Table 127. Germany Needle-free Injection Systems, by Technology USD Million (2014-2019)
  • Table 128. Germany Needle-free Injection Systems, by Medication USD Million (2014-2019)
  • Table 129. Germany Needle-free Injection Systems, by Usability USD Million (2014-2019)
  • Table 130. Germany Needle-free Injection Systems, by Site of Delivery USD Million (2014-2019)
  • Table 131. Germany Needle-free Injection Systems, by End User USD Million (2014-2019)
  • Table 132. France Needle-free Injection Systems, by Type USD Million (2014-2019)
  • Table 133. France Needle-free Injection Systems, by Application USD Million (2014-2019)
  • Table 134. France Needle-free Injection Systems, by Technology USD Million (2014-2019)
  • Table 135. France Needle-free Injection Systems, by Medication USD Million (2014-2019)
  • Table 136. France Needle-free Injection Systems, by Usability USD Million (2014-2019)
  • Table 137. France Needle-free Injection Systems, by Site of Delivery USD Million (2014-2019)
  • Table 138. France Needle-free Injection Systems, by End User USD Million (2014-2019)
  • Table 139. Italy Needle-free Injection Systems, by Type USD Million (2014-2019)
  • Table 140. Italy Needle-free Injection Systems, by Application USD Million (2014-2019)
  • Table 141. Italy Needle-free Injection Systems, by Technology USD Million (2014-2019)
  • Table 142. Italy Needle-free Injection Systems, by Medication USD Million (2014-2019)
  • Table 143. Italy Needle-free Injection Systems, by Usability USD Million (2014-2019)
  • Table 144. Italy Needle-free Injection Systems, by Site of Delivery USD Million (2014-2019)
  • Table 145. Italy Needle-free Injection Systems, by End User USD Million (2014-2019)
  • Table 146. United Kingdom Needle-free Injection Systems, by Type USD Million (2014-2019)
  • Table 147. United Kingdom Needle-free Injection Systems, by Application USD Million (2014-2019)
  • Table 148. United Kingdom Needle-free Injection Systems, by Technology USD Million (2014-2019)
  • Table 149. United Kingdom Needle-free Injection Systems, by Medication USD Million (2014-2019)
  • Table 150. United Kingdom Needle-free Injection Systems, by Usability USD Million (2014-2019)
  • Table 151. United Kingdom Needle-free Injection Systems, by Site of Delivery USD Million (2014-2019)
  • Table 152. United Kingdom Needle-free Injection Systems, by End User USD Million (2014-2019)
  • Table 153. Netherlands Needle-free Injection Systems, by Type USD Million (2014-2019)
  • Table 154. Netherlands Needle-free Injection Systems, by Application USD Million (2014-2019)
  • Table 155. Netherlands Needle-free Injection Systems, by Technology USD Million (2014-2019)
  • Table 156. Netherlands Needle-free Injection Systems, by Medication USD Million (2014-2019)
  • Table 157. Netherlands Needle-free Injection Systems, by Usability USD Million (2014-2019)
  • Table 158. Netherlands Needle-free Injection Systems, by Site of Delivery USD Million (2014-2019)
  • Table 159. Netherlands Needle-free Injection Systems, by End User USD Million (2014-2019)
  • Table 160. Rest of Europe Needle-free Injection Systems, by Type USD Million (2014-2019)
  • Table 161. Rest of Europe Needle-free Injection Systems, by Application USD Million (2014-2019)
  • Table 162. Rest of Europe Needle-free Injection Systems, by Technology USD Million (2014-2019)
  • Table 163. Rest of Europe Needle-free Injection Systems, by Medication USD Million (2014-2019)
  • Table 164. Rest of Europe Needle-free Injection Systems, by Usability USD Million (2014-2019)
  • Table 165. Rest of Europe Needle-free Injection Systems, by Site of Delivery USD Million (2014-2019)
  • Table 166. Rest of Europe Needle-free Injection Systems, by End User USD Million (2014-2019)
  • Table 167. MEA Needle-free Injection Systems, by Country USD Million (2014-2019)
  • Table 168. MEA Needle-free Injection Systems, by Type USD Million (2014-2019)
  • Table 169. MEA Needle-free Injection Systems, by Application USD Million (2014-2019)
  • Table 170. MEA Needle-free Injection Systems, by Technology USD Million (2014-2019)
  • Table 171. MEA Needle-free Injection Systems, by Medication USD Million (2014-2019)
  • Table 172. MEA Needle-free Injection Systems, by Usability USD Million (2014-2019)
  • Table 173. MEA Needle-free Injection Systems, by Site of Delivery USD Million (2014-2019)
  • Table 174. MEA Needle-free Injection Systems, by End User USD Million (2014-2019)
  • Table 175. Middle East Needle-free Injection Systems, by Type USD Million (2014-2019)
  • Table 176. Middle East Needle-free Injection Systems, by Application USD Million (2014-2019)
  • Table 177. Middle East Needle-free Injection Systems, by Technology USD Million (2014-2019)
  • Table 178. Middle East Needle-free Injection Systems, by Medication USD Million (2014-2019)
  • Table 179. Middle East Needle-free Injection Systems, by Usability USD Million (2014-2019)
  • Table 180. Middle East Needle-free Injection Systems, by Site of Delivery USD Million (2014-2019)
  • Table 181. Middle East Needle-free Injection Systems, by End User USD Million (2014-2019)
  • Table 182. Africa Needle-free Injection Systems, by Type USD Million (2014-2019)
  • Table 183. Africa Needle-free Injection Systems, by Application USD Million (2014-2019)
  • Table 184. Africa Needle-free Injection Systems, by Technology USD Million (2014-2019)
  • Table 185. Africa Needle-free Injection Systems, by Medication USD Million (2014-2019)
  • Table 186. Africa Needle-free Injection Systems, by Usability USD Million (2014-2019)
  • Table 187. Africa Needle-free Injection Systems, by Site of Delivery USD Million (2014-2019)
  • Table 188. Africa Needle-free Injection Systems, by End User USD Million (2014-2019)
  • Table 189. North America Needle-free Injection Systems, by Country USD Million (2014-2019)
  • Table 190. North America Needle-free Injection Systems, by Type USD Million (2014-2019)
  • Table 191. North America Needle-free Injection Systems, by Application USD Million (2014-2019)
  • Table 192. North America Needle-free Injection Systems, by Technology USD Million (2014-2019)
  • Table 193. North America Needle-free Injection Systems, by Medication USD Million (2014-2019)
  • Table 194. North America Needle-free Injection Systems, by Usability USD Million (2014-2019)
  • Table 195. North America Needle-free Injection Systems, by Site of Delivery USD Million (2014-2019)
  • Table 196. North America Needle-free Injection Systems, by End User USD Million (2014-2019)
  • Table 197. United States Needle-free Injection Systems, by Type USD Million (2014-2019)
  • Table 198. United States Needle-free Injection Systems, by Application USD Million (2014-2019)
  • Table 199. United States Needle-free Injection Systems, by Technology USD Million (2014-2019)
  • Table 200. United States Needle-free Injection Systems, by Medication USD Million (2014-2019)
  • Table 201. United States Needle-free Injection Systems, by Usability USD Million (2014-2019)
  • Table 202. United States Needle-free Injection Systems, by Site of Delivery USD Million (2014-2019)
  • Table 203. United States Needle-free Injection Systems, by End User USD Million (2014-2019)
  • Table 204. Canada Needle-free Injection Systems, by Type USD Million (2014-2019)
  • Table 205. Canada Needle-free Injection Systems, by Application USD Million (2014-2019)
  • Table 206. Canada Needle-free Injection Systems, by Technology USD Million (2014-2019)
  • Table 207. Canada Needle-free Injection Systems, by Medication USD Million (2014-2019)
  • Table 208. Canada Needle-free Injection Systems, by Usability USD Million (2014-2019)
  • Table 209. Canada Needle-free Injection Systems, by Site of Delivery USD Million (2014-2019)
  • Table 210. Canada Needle-free Injection Systems, by End User USD Million (2014-2019)
  • Table 211. Mexico Needle-free Injection Systems, by Type USD Million (2014-2019)
  • Table 212. Mexico Needle-free Injection Systems, by Application USD Million (2014-2019)
  • Table 213. Mexico Needle-free Injection Systems, by Technology USD Million (2014-2019)
  • Table 214. Mexico Needle-free Injection Systems, by Medication USD Million (2014-2019)
  • Table 215. Mexico Needle-free Injection Systems, by Usability USD Million (2014-2019)
  • Table 216. Mexico Needle-free Injection Systems, by Site of Delivery USD Million (2014-2019)
  • Table 217. Mexico Needle-free Injection Systems, by End User USD Million (2014-2019)
  • Table 218. Needle-free Injection Systems Sales: by Type(K Units)
  • Table 219. Needle-free Injection Systems Sales Fillable Needle-Free Injector , by Region K Units (2014-2019)
  • Table 220. Needle-free Injection Systems Sales Prefilled Needle-Free Injector , by Region K Units (2014-2019)
  • Table 221. Needle-free Injection Systems Sales: by Application(K Units)
  • Table 222. Needle-free Injection Systems Sales Hospitals , by Region K Units (2014-2019)
  • Table 223. Needle-free Injection Systems Sales Clinics , by Region K Units (2014-2019)
  • Table 224. Needle-free Injection Systems Sales Ambulatory Surgical Centers , by Region K Units (2014-2019)
  • Table 225. Needle-free Injection Systems Sales Others , by Region K Units (2014-2019)
  • Table 226. Needle-free Injection Systems Sales: by Technology(K Units)
  • Table 227. Needle-free Injection Systems Sales Jet-Based Needle-Free Injectors , by Region K Units (2014-2019)
  • Table 228. Needle-free Injection Systems Sales Spring-Based Needle-Free Injectors , by Region K Units (2014-2019)
  • Table 229. Needle-free Injection Systems Sales Laser-Powered Needle-Free Injectors , by Region K Units (2014-2019)
  • Table 230. Needle-free Injection Systems Sales Vibration-Based Needle-Free Injectors , by Region K Units (2014-2019)
  • Table 231. Needle-free Injection Systems Sales: by Medication(K Units)
  • Table 232. Needle-free Injection Systems Sales Liquid-based needle-free injectors , by Region K Units (2014-2019)
  • Table 233. Needle-free Injection Systems Sales Powder-based needle-free injectors , by Region K Units (2014-2019)
  • Table 234. Needle-free Injection Systems Sales Projectile/depot-based needle-free injectors , by Region K Units (2014-2019)
  • Table 235. Needle-free Injection Systems Sales: by Usability(K Units)
  • Table 236. Needle-free Injection Systems Sales Reusable Needle-Free Injectors , by Region K Units (2014-2019)
  • Table 237. Needle-free Injection Systems Sales Disposable Needle-Free Injectors , by Region K Units (2014-2019)
  • Table 238. Needle-free Injection Systems Sales: by Site of Delivery(K Units)
  • Table 239. Needle-free Injection Systems Sales Intradermal injectors , by Region K Units (2014-2019)
  • Table 240. Needle-free Injection Systems Sales Intramuscular injectors , by Region K Units (2014-2019)
  • Table 241. Needle-free Injection Systems Sales Subcutaneous injectors , by Region K Units (2014-2019)
  • Table 242. Needle-free Injection Systems Sales: by End User(K Units)
  • Table 243. Needle-free Injection Systems Sales Hospitals and Clinics , by Region K Units (2014-2019)
  • Table 244. Needle-free Injection Systems Sales Homecare Settings , by Region K Units (2014-2019)
  • Table 245. Needle-free Injection Systems Sales Research Laboratories , by Region K Units (2014-2019)
  • Table 246. Needle-free Injection Systems Sales Pharmaceutical and Biotechnology companies , by Region K Units (2014-2019)
  • Table 247. Needle-free Injection Systems Sales End Users , by Region K Units (2014-2019)
  • Table 248. South America Needle-free Injection Systems Sales, by Country K Units (2014-2019)
  • Table 249. South America Needle-free Injection Systems Sales, by Type K Units (2014-2019)
  • Table 250. South America Needle-free Injection Systems Sales, by Application K Units (2014-2019)
  • Table 251. South America Needle-free Injection Systems Sales, by Technology K Units (2014-2019)
  • Table 252. South America Needle-free Injection Systems Sales, by Medication K Units (2014-2019)
  • Table 253. South America Needle-free Injection Systems Sales, by Usability K Units (2014-2019)
  • Table 254. South America Needle-free Injection Systems Sales, by Site of Delivery K Units (2014-2019)
  • Table 255. South America Needle-free Injection Systems Sales, by End User K Units (2014-2019)
  • Table 256. Brazil Needle-free Injection Systems Sales, by Type K Units (2014-2019)
  • Table 257. Brazil Needle-free Injection Systems Sales, by Application K Units (2014-2019)
  • Table 258. Brazil Needle-free Injection Systems Sales, by Technology K Units (2014-2019)
  • Table 259. Brazil Needle-free Injection Systems Sales, by Medication K Units (2014-2019)
  • Table 260. Brazil Needle-free Injection Systems Sales, by Usability K Units (2014-2019)
  • Table 261. Brazil Needle-free Injection Systems Sales, by Site of Delivery K Units (2014-2019)
  • Table 262. Brazil Needle-free Injection Systems Sales, by End User K Units (2014-2019)
  • Table 263. Argentina Needle-free Injection Systems Sales, by Type K Units (2014-2019)
  • Table 264. Argentina Needle-free Injection Systems Sales, by Application K Units (2014-2019)
  • Table 265. Argentina Needle-free Injection Systems Sales, by Technology K Units (2014-2019)
  • Table 266. Argentina Needle-free Injection Systems Sales, by Medication K Units (2014-2019)
  • Table 267. Argentina Needle-free Injection Systems Sales, by Usability K Units (2014-2019)
  • Table 268. Argentina Needle-free Injection Systems Sales, by Site of Delivery K Units (2014-2019)
  • Table 269. Argentina Needle-free Injection Systems Sales, by End User K Units (2014-2019)
  • Table 270. Rest of South America Needle-free Injection Systems Sales, by Type K Units (2014-2019)
  • Table 271. Rest of South America Needle-free Injection Systems Sales, by Application K Units (2014-2019)
  • Table 272. Rest of South America Needle-free Injection Systems Sales, by Technology K Units (2014-2019)
  • Table 273. Rest of South America Needle-free Injection Systems Sales, by Medication K Units (2014-2019)
  • Table 274. Rest of South America Needle-free Injection Systems Sales, by Usability K Units (2014-2019)
  • Table 275. Rest of South America Needle-free Injection Systems Sales, by Site of Delivery K Units (2014-2019)
  • Table 276. Rest of South America Needle-free Injection Systems Sales, by End User K Units (2014-2019)
  • Table 277. Asia Pacific Needle-free Injection Systems Sales, by Country K Units (2014-2019)
  • Table 278. Asia Pacific Needle-free Injection Systems Sales, by Type K Units (2014-2019)
  • Table 279. Asia Pacific Needle-free Injection Systems Sales, by Application K Units (2014-2019)
  • Table 280. Asia Pacific Needle-free Injection Systems Sales, by Technology K Units (2014-2019)
  • Table 281. Asia Pacific Needle-free Injection Systems Sales, by Medication K Units (2014-2019)
  • Table 282. Asia Pacific Needle-free Injection Systems Sales, by Usability K Units (2014-2019)
  • Table 283. Asia Pacific Needle-free Injection Systems Sales, by Site of Delivery K Units (2014-2019)
  • Table 284. Asia Pacific Needle-free Injection Systems Sales, by End User K Units (2014-2019)
  • Table 285. China Needle-free Injection Systems Sales, by Type K Units (2014-2019)
  • Table 286. China Needle-free Injection Systems Sales, by Application K Units (2014-2019)
  • Table 287. China Needle-free Injection Systems Sales, by Technology K Units (2014-2019)
  • Table 288. China Needle-free Injection Systems Sales, by Medication K Units (2014-2019)
  • Table 289. China Needle-free Injection Systems Sales, by Usability K Units (2014-2019)
  • Table 290. China Needle-free Injection Systems Sales, by Site of Delivery K Units (2014-2019)
  • Table 291. China Needle-free Injection Systems Sales, by End User K Units (2014-2019)
  • Table 292. Japan Needle-free Injection Systems Sales, by Type K Units (2014-2019)
  • Table 293. Japan Needle-free Injection Systems Sales, by Application K Units (2014-2019)
  • Table 294. Japan Needle-free Injection Systems Sales, by Technology K Units (2014-2019)
  • Table 295. Japan Needle-free Injection Systems Sales, by Medication K Units (2014-2019)
  • Table 296. Japan Needle-free Injection Systems Sales, by Usability K Units (2014-2019)
  • Table 297. Japan Needle-free Injection Systems Sales, by Site of Delivery K Units (2014-2019)
  • Table 298. Japan Needle-free Injection Systems Sales, by End User K Units (2014-2019)
  • Table 299. India Needle-free Injection Systems Sales, by Type K Units (2014-2019)
  • Table 300. India Needle-free Injection Systems Sales, by Application K Units (2014-2019)
  • Table 301. India Needle-free Injection Systems Sales, by Technology K Units (2014-2019)
  • Table 302. India Needle-free Injection Systems Sales, by Medication K Units (2014-2019)
  • Table 303. India Needle-free Injection Systems Sales, by Usability K Units (2014-2019)
  • Table 304. India Needle-free Injection Systems Sales, by Site of Delivery K Units (2014-2019)
  • Table 305. India Needle-free Injection Systems Sales, by End User K Units (2014-2019)
  • Table 306. South Korea Needle-free Injection Systems Sales, by Type K Units (2014-2019)
  • Table 307. South Korea Needle-free Injection Systems Sales, by Application K Units (2014-2019)
  • Table 308. South Korea Needle-free Injection Systems Sales, by Technology K Units (2014-2019)
  • Table 309. South Korea Needle-free Injection Systems Sales, by Medication K Units (2014-2019)
  • Table 310. South Korea Needle-free Injection Systems Sales, by Usability K Units (2014-2019)
  • Table 311. South Korea Needle-free Injection Systems Sales, by Site of Delivery K Units (2014-2019)
  • Table 312. South Korea Needle-free Injection Systems Sales, by End User K Units (2014-2019)
  • Table 313. Taiwan Needle-free Injection Systems Sales, by Type K Units (2014-2019)
  • Table 314. Taiwan Needle-free Injection Systems Sales, by Application K Units (2014-2019)
  • Table 315. Taiwan Needle-free Injection Systems Sales, by Technology K Units (2014-2019)
  • Table 316. Taiwan Needle-free Injection Systems Sales, by Medication K Units (2014-2019)
  • Table 317. Taiwan Needle-free Injection Systems Sales, by Usability K Units (2014-2019)
  • Table 318. Taiwan Needle-free Injection Systems Sales, by Site of Delivery K Units (2014-2019)
  • Table 319. Taiwan Needle-free Injection Systems Sales, by End User K Units (2014-2019)
  • Table 320. Australia Needle-free Injection Systems Sales, by Type K Units (2014-2019)
  • Table 321. Australia Needle-free Injection Systems Sales, by Application K Units (2014-2019)
  • Table 322. Australia Needle-free Injection Systems Sales, by Technology K Units (2014-2019)
  • Table 323. Australia Needle-free Injection Systems Sales, by Medication K Units (2014-2019)
  • Table 324. Australia Needle-free Injection Systems Sales, by Usability K Units (2014-2019)
  • Table 325. Australia Needle-free Injection Systems Sales, by Site of Delivery K Units (2014-2019)
  • Table 326. Australia Needle-free Injection Systems Sales, by End User K Units (2014-2019)
  • Table 327. Rest of Asia-Pacific Needle-free Injection Systems Sales, by Type K Units (2014-2019)
  • Table 328. Rest of Asia-Pacific Needle-free Injection Systems Sales, by Application K Units (2014-2019)
  • Table 329. Rest of Asia-Pacific Needle-free Injection Systems Sales, by Technology K Units (2014-2019)
  • Table 330. Rest of Asia-Pacific Needle-free Injection Systems Sales, by Medication K Units (2014-2019)
  • Table 331. Rest of Asia-Pacific Needle-free Injection Systems Sales, by Usability K Units (2014-2019)
  • Table 332. Rest of Asia-Pacific Needle-free Injection Systems Sales, by Site of Delivery K Units (2014-2019)
  • Table 333. Rest of Asia-Pacific Needle-free Injection Systems Sales, by End User K Units (2014-2019)
  • Table 334. Europe Needle-free Injection Systems Sales, by Country K Units (2014-2019)
  • Table 335. Europe Needle-free Injection Systems Sales, by Type K Units (2014-2019)
  • Table 336. Europe Needle-free Injection Systems Sales, by Application K Units (2014-2019)
  • Table 337. Europe Needle-free Injection Systems Sales, by Technology K Units (2014-2019)
  • Table 338. Europe Needle-free Injection Systems Sales, by Medication K Units (2014-2019)
  • Table 339. Europe Needle-free Injection Systems Sales, by Usability K Units (2014-2019)
  • Table 340. Europe Needle-free Injection Systems Sales, by Site of Delivery K Units (2014-2019)
  • Table 341. Europe Needle-free Injection Systems Sales, by End User K Units (2014-2019)
  • Table 342. Germany Needle-free Injection Systems Sales, by Type K Units (2014-2019)
  • Table 343. Germany Needle-free Injection Systems Sales, by Application K Units (2014-2019)
  • Table 344. Germany Needle-free Injection Systems Sales, by Technology K Units (2014-2019)
  • Table 345. Germany Needle-free Injection Systems Sales, by Medication K Units (2014-2019)
  • Table 346. Germany Needle-free Injection Systems Sales, by Usability K Units (2014-2019)
  • Table 347. Germany Needle-free Injection Systems Sales, by Site of Delivery K Units (2014-2019)
  • Table 348. Germany Needle-free Injection Systems Sales, by End User K Units (2014-2019)
  • Table 349. France Needle-free Injection Systems Sales, by Type K Units (2014-2019)
  • Table 350. France Needle-free Injection Systems Sales, by Application K Units (2014-2019)
  • Table 351. France Needle-free Injection Systems Sales, by Technology K Units (2014-2019)
  • Table 352. France Needle-free Injection Systems Sales, by Medication K Units (2014-2019)
  • Table 353. France Needle-free Injection Systems Sales, by Usability K Units (2014-2019)
  • Table 354. France Needle-free Injection Systems Sales, by Site of Delivery K Units (2014-2019)
  • Table 355. France Needle-free Injection Systems Sales, by End User K Units (2014-2019)
  • Table 356. Italy Needle-free Injection Systems Sales, by Type K Units (2014-2019)
  • Table 357. Italy Needle-free Injection Systems Sales, by Application K Units (2014-2019)
  • Table 358. Italy Needle-free Injection Systems Sales, by Technology K Units (2014-2019)
  • Table 359. Italy Needle-free Injection Systems Sales, by Medication K Units (2014-2019)
  • Table 360. Italy Needle-free Injection Systems Sales, by Usability K Units (2014-2019)
  • Table 361. Italy Needle-free Injection Systems Sales, by Site of Delivery K Units (2014-2019)
  • Table 362. Italy Needle-free Injection Systems Sales, by End User K Units (2014-2019)
  • Table 363. United Kingdom Needle-free Injection Systems Sales, by Type K Units (2014-2019)
  • Table 364. United Kingdom Needle-free Injection Systems Sales, by Application K Units (2014-2019)
  • Table 365. United Kingdom Needle-free Injection Systems Sales, by Technology K Units (2014-2019)
  • Table 366. United Kingdom Needle-free Injection Systems Sales, by Medication K Units (2014-2019)
  • Table 367. United Kingdom Needle-free Injection Systems Sales, by Usability K Units (2014-2019)
  • Table 368. United Kingdom Needle-free Injection Systems Sales, by Site of Delivery K Units (2014-2019)
  • Table 369. United Kingdom Needle-free Injection Systems Sales, by End User K Units (2014-2019)
  • Table 370. Netherlands Needle-free Injection Systems Sales, by Type K Units (2014-2019)
  • Table 371. Netherlands Needle-free Injection Systems Sales, by Application K Units (2014-2019)
  • Table 372. Netherlands Needle-free Injection Systems Sales, by Technology K Units (2014-2019)
  • Table 373. Netherlands Needle-free Injection Systems Sales, by Medication K Units (2014-2019)
  • Table 374. Netherlands Needle-free Injection Systems Sales, by Usability K Units (2014-2019)
  • Table 375. Netherlands Needle-free Injection Systems Sales, by Site of Delivery K Units (2014-2019)
  • Table 376. Netherlands Needle-free Injection Systems Sales, by End User K Units (2014-2019)
  • Table 377. Rest of Europe Needle-free Injection Systems Sales, by Type K Units (2014-2019)
  • Table 378. Rest of Europe Needle-free Injection Systems Sales, by Application K Units (2014-2019)
  • Table 379. Rest of Europe Needle-free Injection Systems Sales, by Technology K Units (2014-2019)
  • Table 380. Rest of Europe Needle-free Injection Systems Sales, by Medication K Units (2014-2019)
  • Table 381. Rest of Europe Needle-free Injection Systems Sales, by Usability K Units (2014-2019)
  • Table 382. Rest of Europe Needle-free Injection Systems Sales, by Site of Delivery K Units (2014-2019)
  • Table 383. Rest of Europe Needle-free Injection Systems Sales, by End User K Units (2014-2019)
  • Table 384. MEA Needle-free Injection Systems Sales, by Country K Units (2014-2019)
  • Table 385. MEA Needle-free Injection Systems Sales, by Type K Units (2014-2019)
  • Table 386. MEA Needle-free Injection Systems Sales, by Application K Units (2014-2019)
  • Table 387. MEA Needle-free Injection Systems Sales, by Technology K Units (2014-2019)
  • Table 388. MEA Needle-free Injection Systems Sales, by Medication K Units (2014-2019)
  • Table 389. MEA Needle-free Injection Systems Sales, by Usability K Units (2014-2019)
  • Table 390. MEA Needle-free Injection Systems Sales, by Site of Delivery K Units (2014-2019)
  • Table 391. MEA Needle-free Injection Systems Sales, by End User K Units (2014-2019)
  • Table 392. Middle East Needle-free Injection Systems Sales, by Type K Units (2014-2019)
  • Table 393. Middle East Needle-free Injection Systems Sales, by Application K Units (2014-2019)
  • Table 394. Middle East Needle-free Injection Systems Sales, by Technology K Units (2014-2019)
  • Table 395. Middle East Needle-free Injection Systems Sales, by Medication K Units (2014-2019)
  • Table 396. Middle East Needle-free Injection Systems Sales, by Usability K Units (2014-2019)
  • Table 397. Middle East Needle-free Injection Systems Sales, by Site of Delivery K Units (2014-2019)
  • Table 398. Middle East Needle-free Injection Systems Sales, by End User K Units (2014-2019)
  • Table 399. Africa Needle-free Injection Systems Sales, by Type K Units (2014-2019)
  • Table 400. Africa Needle-free Injection Systems Sales, by Application K Units (2014-2019)
  • Table 401. Africa Needle-free Injection Systems Sales, by Technology K Units (2014-2019)
  • Table 402. Africa Needle-free Injection Systems Sales, by Medication K Units (2014-2019)
  • Table 403. Africa Needle-free Injection Systems Sales, by Usability K Units (2014-2019)
  • Table 404. Africa Needle-free Injection Systems Sales, by Site of Delivery K Units (2014-2019)
  • Table 405. Africa Needle-free Injection Systems Sales, by End User K Units (2014-2019)
  • Table 406. North America Needle-free Injection Systems Sales, by Country K Units (2014-2019)
  • Table 407. North America Needle-free Injection Systems Sales, by Type K Units (2014-2019)
  • Table 408. North America Needle-free Injection Systems Sales, by Application K Units (2014-2019)
  • Table 409. North America Needle-free Injection Systems Sales, by Technology K Units (2014-2019)
  • Table 410. North America Needle-free Injection Systems Sales, by Medication K Units (2014-2019)
  • Table 411. North America Needle-free Injection Systems Sales, by Usability K Units (2014-2019)
  • Table 412. North America Needle-free Injection Systems Sales, by Site of Delivery K Units (2014-2019)
  • Table 413. North America Needle-free Injection Systems Sales, by End User K Units (2014-2019)
  • Table 414. United States Needle-free Injection Systems Sales, by Type K Units (2014-2019)
  • Table 415. United States Needle-free Injection Systems Sales, by Application K Units (2014-2019)
  • Table 416. United States Needle-free Injection Systems Sales, by Technology K Units (2014-2019)
  • Table 417. United States Needle-free Injection Systems Sales, by Medication K Units (2014-2019)
  • Table 418. United States Needle-free Injection Systems Sales, by Usability K Units (2014-2019)
  • Table 419. United States Needle-free Injection Systems Sales, by Site of Delivery K Units (2014-2019)
  • Table 420. United States Needle-free Injection Systems Sales, by End User K Units (2014-2019)
  • Table 421. Canada Needle-free Injection Systems Sales, by Type K Units (2014-2019)
  • Table 422. Canada Needle-free Injection Systems Sales, by Application K Units (2014-2019)
  • Table 423. Canada Needle-free Injection Systems Sales, by Technology K Units (2014-2019)
  • Table 424. Canada Needle-free Injection Systems Sales, by Medication K Units (2014-2019)
  • Table 425. Canada Needle-free Injection Systems Sales, by Usability K Units (2014-2019)
  • Table 426. Canada Needle-free Injection Systems Sales, by Site of Delivery K Units (2014-2019)
  • Table 427. Canada Needle-free Injection Systems Sales, by End User K Units (2014-2019)
  • Table 428. Mexico Needle-free Injection Systems Sales, by Type K Units (2014-2019)
  • Table 429. Mexico Needle-free Injection Systems Sales, by Application K Units (2014-2019)
  • Table 430. Mexico Needle-free Injection Systems Sales, by Technology K Units (2014-2019)
  • Table 431. Mexico Needle-free Injection Systems Sales, by Medication K Units (2014-2019)
  • Table 432. Mexico Needle-free Injection Systems Sales, by Usability K Units (2014-2019)
  • Table 433. Mexico Needle-free Injection Systems Sales, by Site of Delivery K Units (2014-2019)
  • Table 434. Mexico Needle-free Injection Systems Sales, by End User K Units (2014-2019)
  • Table 435. Needle-free Injection Systems: by Type(USD/Units)
  • Table 436. Company Basic Information, Sales Area and Its Competitors
  • Table 437. Company Basic Information, Sales Area and Its Competitors
  • Table 438. Company Basic Information, Sales Area and Its Competitors
  • Table 439. Company Basic Information, Sales Area and Its Competitors
  • Table 440. Company Basic Information, Sales Area and Its Competitors
  • Table 441. Company Basic Information, Sales Area and Its Competitors
  • Table 442. Company Basic Information, Sales Area and Its Competitors
  • Table 443. Company Basic Information, Sales Area and Its Competitors
  • Table 444. Company Basic Information, Sales Area and Its Competitors
  • Table 445. Company Basic Information, Sales Area and Its Competitors
  • Table 446. Needle-free Injection Systems: by Type(USD Million)
  • Table 447. Needle-free Injection Systems Fillable Needle-Free Injector , by Region USD Million (2020-2025)
  • Table 448. Needle-free Injection Systems Prefilled Needle-Free Injector , by Region USD Million (2020-2025)
  • Table 449. Needle-free Injection Systems: by Application(USD Million)
  • Table 450. Needle-free Injection Systems Hospitals , by Region USD Million (2020-2025)
  • Table 451. Needle-free Injection Systems Clinics , by Region USD Million (2020-2025)
  • Table 452. Needle-free Injection Systems Ambulatory Surgical Centers , by Region USD Million (2020-2025)
  • Table 453. Needle-free Injection Systems Others , by Region USD Million (2020-2025)
  • Table 454. Needle-free Injection Systems: by Technology(USD Million)
  • Table 455. Needle-free Injection Systems Jet-Based Needle-Free Injectors , by Region USD Million (2020-2025)
  • Table 456. Needle-free Injection Systems Spring-Based Needle-Free Injectors , by Region USD Million (2020-2025)
  • Table 457. Needle-free Injection Systems Laser-Powered Needle-Free Injectors , by Region USD Million (2020-2025)
  • Table 458. Needle-free Injection Systems Vibration-Based Needle-Free Injectors , by Region USD Million (2020-2025)
  • Table 459. Needle-free Injection Systems: by Medication(USD Million)
  • Table 460. Needle-free Injection Systems Liquid-based needle-free injectors , by Region USD Million (2020-2025)
  • Table 461. Needle-free Injection Systems Powder-based needle-free injectors , by Region USD Million (2020-2025)
  • Table 462. Needle-free Injection Systems Projectile/depot-based needle-free injectors , by Region USD Million (2020-2025)
  • Table 463. Needle-free Injection Systems: by Usability(USD Million)
  • Table 464. Needle-free Injection Systems Reusable Needle-Free Injectors , by Region USD Million (2020-2025)
  • Table 465. Needle-free Injection Systems Disposable Needle-Free Injectors , by Region USD Million (2020-2025)
  • Table 466. Needle-free Injection Systems: by Site of Delivery(USD Million)
  • Table 467. Needle-free Injection Systems Intradermal injectors , by Region USD Million (2020-2025)
  • Table 468. Needle-free Injection Systems Intramuscular injectors , by Region USD Million (2020-2025)
  • Table 469. Needle-free Injection Systems Subcutaneous injectors , by Region USD Million (2020-2025)
  • Table 470. Needle-free Injection Systems: by End User(USD Million)
  • Table 471. Needle-free Injection Systems Hospitals and Clinics , by Region USD Million (2020-2025)
  • Table 472. Needle-free Injection Systems Homecare Settings , by Region USD Million (2020-2025)
  • Table 473. Needle-free Injection Systems Research Laboratories , by Region USD Million (2020-2025)
  • Table 474. Needle-free Injection Systems Pharmaceutical and Biotechnology companies , by Region USD Million (2020-2025)
  • Table 475. Needle-free Injection Systems End Users , by Region USD Million (2020-2025)
  • Table 476. South America Needle-free Injection Systems, by Country USD Million (2020-2025)
  • Table 477. South America Needle-free Injection Systems, by Type USD Million (2020-2025)
  • Table 478. South America Needle-free Injection Systems, by Application USD Million (2020-2025)
  • Table 479. South America Needle-free Injection Systems, by Technology USD Million (2020-2025)
  • Table 480. South America Needle-free Injection Systems, by Medication USD Million (2020-2025)
  • Table 481. South America Needle-free Injection Systems, by Usability USD Million (2020-2025)
  • Table 482. South America Needle-free Injection Systems, by Site of Delivery USD Million (2020-2025)
  • Table 483. South America Needle-free Injection Systems, by End User USD Million (2020-2025)
  • Table 484. Brazil Needle-free Injection Systems, by Type USD Million (2020-2025)
  • Table 485. Brazil Needle-free Injection Systems, by Application USD Million (2020-2025)
  • Table 486. Brazil Needle-free Injection Systems, by Technology USD Million (2020-2025)
  • Table 487. Brazil Needle-free Injection Systems, by Medication USD Million (2020-2025)
  • Table 488. Brazil Needle-free Injection Systems, by Usability USD Million (2020-2025)
  • Table 489. Brazil Needle-free Injection Systems, by Site of Delivery USD Million (2020-2025)
  • Table 490. Brazil Needle-free Injection Systems, by End User USD Million (2020-2025)
  • Table 491. Argentina Needle-free Injection Systems, by Type USD Million (2020-2025)
  • Table 492. Argentina Needle-free Injection Systems, by Application USD Million (2020-2025)
  • Table 493. Argentina Needle-free Injection Systems, by Technology USD Million (2020-2025)
  • Table 494. Argentina Needle-free Injection Systems, by Medication USD Million (2020-2025)
  • Table 495. Argentina Needle-free Injection Systems, by Usability USD Million (2020-2025)
  • Table 496. Argentina Needle-free Injection Systems, by Site of Delivery USD Million (2020-2025)
  • Table 497. Argentina Needle-free Injection Systems, by End User USD Million (2020-2025)
  • Table 498. Rest of South America Needle-free Injection Systems, by Type USD Million (2020-2025)
  • Table 499. Rest of South America Needle-free Injection Systems, by Application USD Million (2020-2025)
  • Table 500. Rest of South America Needle-free Injection Systems, by Technology USD Million (2020-2025)
  • Table 501. Rest of South America Needle-free Injection Systems, by Medication USD Million (2020-2025)
  • Table 502. Rest of South America Needle-free Injection Systems, by Usability USD Million (2020-2025)
  • Table 503. Rest of South America Needle-free Injection Systems, by Site of Delivery USD Million (2020-2025)
  • Table 504. Rest of South America Needle-free Injection Systems, by End User USD Million (2020-2025)
  • Table 505. Asia Pacific Needle-free Injection Systems, by Country USD Million (2020-2025)
  • Table 506. Asia Pacific Needle-free Injection Systems, by Type USD Million (2020-2025)
  • Table 507. Asia Pacific Needle-free Injection Systems, by Application USD Million (2020-2025)
  • Table 508. Asia Pacific Needle-free Injection Systems, by Technology USD Million (2020-2025)
  • Table 509. Asia Pacific Needle-free Injection Systems, by Medication USD Million (2020-2025)
  • Table 510. Asia Pacific Needle-free Injection Systems, by Usability USD Million (2020-2025)
  • Table 511. Asia Pacific Needle-free Injection Systems, by Site of Delivery USD Million (2020-2025)
  • Table 512. Asia Pacific Needle-free Injection Systems, by End User USD Million (2020-2025)
  • Table 513. China Needle-free Injection Systems, by Type USD Million (2020-2025)
  • Table 514. China Needle-free Injection Systems, by Application USD Million (2020-2025)
  • Table 515. China Needle-free Injection Systems, by Technology USD Million (2020-2025)
  • Table 516. China Needle-free Injection Systems, by Medication USD Million (2020-2025)
  • Table 517. China Needle-free Injection Systems, by Usability USD Million (2020-2025)
  • Table 518. China Needle-free Injection Systems, by Site of Delivery USD Million (2020-2025)
  • Table 519. China Needle-free Injection Systems, by End User USD Million (2020-2025)
  • Table 520. Japan Needle-free Injection Systems, by Type USD Million (2020-2025)
  • Table 521. Japan Needle-free Injection Systems, by Application USD Million (2020-2025)
  • Table 522. Japan Needle-free Injection Systems, by Technology USD Million (2020-2025)
  • Table 523. Japan Needle-free Injection Systems, by Medication USD Million (2020-2025)
  • Table 524. Japan Needle-free Injection Systems, by Usability USD Million (2020-2025)
  • Table 525. Japan Needle-free Injection Systems, by Site of Delivery USD Million (2020-2025)
  • Table 526. Japan Needle-free Injection Systems, by End User USD Million (2020-2025)
  • Table 527. India Needle-free Injection Systems, by Type USD Million (2020-2025)
  • Table 528. India Needle-free Injection Systems, by Application USD Million (2020-2025)
  • Table 529. India Needle-free Injection Systems, by Technology USD Million (2020-2025)
  • Table 530. India Needle-free Injection Systems, by Medication USD Million (2020-2025)
  • Table 531. India Needle-free Injection Systems, by Usability USD Million (2020-2025)
  • Table 532. India Needle-free Injection Systems, by Site of Delivery USD Million (2020-2025)
  • Table 533. India Needle-free Injection Systems, by End User USD Million (2020-2025)
  • Table 534. South Korea Needle-free Injection Systems, by Type USD Million (2020-2025)
  • Table 535. South Korea Needle-free Injection Systems, by Application USD Million (2020-2025)
  • Table 536. South Korea Needle-free Injection Systems, by Technology USD Million (2020-2025)
  • Table 537. South Korea Needle-free Injection Systems, by Medication USD Million (2020-2025)
  • Table 538. South Korea Needle-free Injection Systems, by Usability USD Million (2020-2025)
  • Table 539. South Korea Needle-free Injection Systems, by Site of Delivery USD Million (2020-2025)
  • Table 540. South Korea Needle-free Injection Systems, by End User USD Million (2020-2025)
  • Table 541. Taiwan Needle-free Injection Systems, by Type USD Million (2020-2025)
  • Table 542. Taiwan Needle-free Injection Systems, by Application USD Million (2020-2025)
  • Table 543. Taiwan Needle-free Injection Systems, by Technology USD Million (2020-2025)
  • Table 544. Taiwan Needle-free Injection Systems, by Medication USD Million (2020-2025)
  • Table 545. Taiwan Needle-free Injection Systems, by Usability USD Million (2020-2025)
  • Table 546. Taiwan Needle-free Injection Systems, by Site of Delivery USD Million (2020-2025)
  • Table 547. Taiwan Needle-free Injection Systems, by End User USD Million (2020-2025)
  • Table 548. Australia Needle-free Injection Systems, by Type USD Million (2020-2025)
  • Table 549. Australia Needle-free Injection Systems, by Application USD Million (2020-2025)
  • Table 550. Australia Needle-free Injection Systems, by Technology USD Million (2020-2025)
  • Table 551. Australia Needle-free Injection Systems, by Medication USD Million (2020-2025)
  • Table 552. Australia Needle-free Injection Systems, by Usability USD Million (2020-2025)
  • Table 553. Australia Needle-free Injection Systems, by Site of Delivery USD Million (2020-2025)
  • Table 554. Australia Needle-free Injection Systems, by End User USD Million (2020-2025)
  • Table 555. Rest of Asia-Pacific Needle-free Injection Systems, by Type USD Million (2020-2025)
  • Table 556. Rest of Asia-Pacific Needle-free Injection Systems, by Application USD Million (2020-2025)
  • Table 557. Rest of Asia-Pacific Needle-free Injection Systems, by Technology USD Million (2020-2025)
  • Table 558. Rest of Asia-Pacific Needle-free Injection Systems, by Medication USD Million (2020-2025)
  • Table 559. Rest of Asia-Pacific Needle-free Injection Systems, by Usability USD Million (2020-2025)
  • Table 560. Rest of Asia-Pacific Needle-free Injection Systems, by Site of Delivery USD Million (2020-2025)
  • Table 561. Rest of Asia-Pacific Needle-free Injection Systems, by End User USD Million (2020-2025)
  • Table 562. Europe Needle-free Injection Systems, by Country USD Million (2020-2025)
  • Table 563. Europe Needle-free Injection Systems, by Type USD Million (2020-2025)
  • Table 564. Europe Needle-free Injection Systems, by Application USD Million (2020-2025)
  • Table 565. Europe Needle-free Injection Systems, by Technology USD Million (2020-2025)
  • Table 566. Europe Needle-free Injection Systems, by Medication USD Million (2020-2025)
  • Table 567. Europe Needle-free Injection Systems, by Usability USD Million (2020-2025)
  • Table 568. Europe Needle-free Injection Systems, by Site of Delivery USD Million (2020-2025)
  • Table 569. Europe Needle-free Injection Systems, by End User USD Million (2020-2025)
  • Table 570. Germany Needle-free Injection Systems, by Type USD Million (2020-2025)
  • Table 571. Germany Needle-free Injection Systems, by Application USD Million (2020-2025)
  • Table 572. Germany Needle-free Injection Systems, by Technology USD Million (2020-2025)
  • Table 573. Germany Needle-free Injection Systems, by Medication USD Million (2020-2025)
  • Table 574. Germany Needle-free Injection Systems, by Usability USD Million (2020-2025)
  • Table 575. Germany Needle-free Injection Systems, by Site of Delivery USD Million (2020-2025)
  • Table 576. Germany Needle-free Injection Systems, by End User USD Million (2020-2025)
  • Table 577. France Needle-free Injection Systems, by Type USD Million (2020-2025)
  • Table 578. France Needle-free Injection Systems, by Application USD Million (2020-2025)
  • Table 579. France Needle-free Injection Systems, by Technology USD Million (2020-2025)
  • Table 580. France Needle-free Injection Systems, by Medication USD Million (2020-2025)
  • Table 581. France Needle-free Injection Systems, by Usability USD Million (2020-2025)
  • Table 582. France Needle-free Injection Systems, by Site of Delivery USD Million (2020-2025)
  • Table 583. France Needle-free Injection Systems, by End User USD Million (2020-2025)
  • Table 584. Italy Needle-free Injection Systems, by Type USD Million (2020-2025)
  • Table 585. Italy Needle-free Injection Systems, by Application USD Million (2020-2025)
  • Table 586. Italy Needle-free Injection Systems, by Technology USD Million (2020-2025)
  • Table 587. Italy Needle-free Injection Systems, by Medication USD Million (2020-2025)
  • Table 588. Italy Needle-free Injection Systems, by Usability USD Million (2020-2025)
  • Table 589. Italy Needle-free Injection Systems, by Site of Delivery USD Million (2020-2025)
  • Table 590. Italy Needle-free Injection Systems, by End User USD Million (2020-2025)
  • Table 591. United Kingdom Needle-free Injection Systems, by Type USD Million (2020-2025)
  • Table 592. United Kingdom Needle-free Injection Systems, by Application USD Million (2020-2025)
  • Table 593. United Kingdom Needle-free Injection Systems, by Technology USD Million (2020-2025)
  • Table 594. United Kingdom Needle-free Injection Systems, by Medication USD Million (2020-2025)
  • Table 595. United Kingdom Needle-free Injection Systems, by Usability USD Million (2020-2025)
  • Table 596. United Kingdom Needle-free Injection Systems, by Site of Delivery USD Million (2020-2025)
  • Table 597. United Kingdom Needle-free Injection Systems, by End User USD Million (2020-2025)
  • Table 598. Netherlands Needle-free Injection Systems, by Type USD Million (2020-2025)
  • Table 599. Netherlands Needle-free Injection Systems, by Application USD Million (2020-2025)
  • Table 600. Netherlands Needle-free Injection Systems, by Technology USD Million (2020-2025)
  • Table 601. Netherlands Needle-free Injection Systems, by Medication USD Million (2020-2025)
  • Table 602. Netherlands Needle-free Injection Systems, by Usability USD Million (2020-2025)
  • Table 603. Netherlands Needle-free Injection Systems, by Site of Delivery USD Million (2020-2025)
  • Table 604. Netherlands Needle-free Injection Systems, by End User USD Million (2020-2025)
  • Table 605. Rest of Europe Needle-free Injection Systems, by Type USD Million (2020-2025)
  • Table 606. Rest of Europe Needle-free Injection Systems, by Application USD Million (2020-2025)
  • Table 607. Rest of Europe Needle-free Injection Systems, by Technology USD Million (2020-2025)
  • Table 608. Rest of Europe Needle-free Injection Systems, by Medication USD Million (2020-2025)
  • Table 609. Rest of Europe Needle-free Injection Systems, by Usability USD Million (2020-2025)
  • Table 610. Rest of Europe Needle-free Injection Systems, by Site of Delivery USD Million (2020-2025)
  • Table 611. Rest of Europe Needle-free Injection Systems, by End User USD Million (2020-2025)
  • Table 612. MEA Needle-free Injection Systems, by Country USD Million (2020-2025)
  • Table 613. MEA Needle-free Injection Systems, by Type USD Million (2020-2025)
  • Table 614. MEA Needle-free Injection Systems, by Application USD Million (2020-2025)
  • Table 615. MEA Needle-free Injection Systems, by Technology USD Million (2020-2025)
  • Table 616. MEA Needle-free Injection Systems, by Medication USD Million (2020-2025)
  • Table 617. MEA Needle-free Injection Systems, by Usability USD Million (2020-2025)
  • Table 618. MEA Needle-free Injection Systems, by Site of Delivery USD Million (2020-2025)
  • Table 619. MEA Needle-free Injection Systems, by End User USD Million (2020-2025)
  • Table 620. Middle East Needle-free Injection Systems, by Type USD Million (2020-2025)
  • Table 621. Middle East Needle-free Injection Systems, by Application USD Million (2020-2025)
  • Table 622. Middle East Needle-free Injection Systems, by Technology USD Million (2020-2025)
  • Table 623. Middle East Needle-free Injection Systems, by Medication USD Million (2020-2025)
  • Table 624. Middle East Needle-free Injection Systems, by Usability USD Million (2020-2025)
  • Table 625. Middle East Needle-free Injection Systems, by Site of Delivery USD Million (2020-2025)
  • Table 626. Middle East Needle-free Injection Systems, by End User USD Million (2020-2025)
  • Table 627. Africa Needle-free Injection Systems, by Type USD Million (2020-2025)
  • Table 628. Africa Needle-free Injection Systems, by Application USD Million (2020-2025)
  • Table 629. Africa Needle-free Injection Systems, by Technology USD Million (2020-2025)
  • Table 630. Africa Needle-free Injection Systems, by Medication USD Million (2020-2025)
  • Table 631. Africa Needle-free Injection Systems, by Usability USD Million (2020-2025)
  • Table 632. Africa Needle-free Injection Systems, by Site of Delivery USD Million (2020-2025)
  • Table 633. Africa Needle-free Injection Systems, by End User USD Million (2020-2025)
  • Table 634. North America Needle-free Injection Systems, by Country USD Million (2020-2025)
  • Table 635. North America Needle-free Injection Systems, by Type USD Million (2020-2025)
  • Table 636. North America Needle-free Injection Systems, by Application USD Million (2020-2025)
  • Table 637. North America Needle-free Injection Systems, by Technology USD Million (2020-2025)
  • Table 638. North America Needle-free Injection Systems, by Medication USD Million (2020-2025)
  • Table 639. North America Needle-free Injection Systems, by Usability USD Million (2020-2025)
  • Table 640. North America Needle-free Injection Systems, by Site of Delivery USD Million (2020-2025)
  • Table 641. North America Needle-free Injection Systems, by End User USD Million (2020-2025)
  • Table 642. United States Needle-free Injection Systems, by Type USD Million (2020-2025)
  • Table 643. United States Needle-free Injection Systems, by Application USD Million (2020-2025)
  • Table 644. United States Needle-free Injection Systems, by Technology USD Million (2020-2025)
  • Table 645. United States Needle-free Injection Systems, by Medication USD Million (2020-2025)
  • Table 646. United States Needle-free Injection Systems, by Usability USD Million (2020-2025)
  • Table 647. United States Needle-free Injection Systems, by Site of Delivery USD Million (2020-2025)
  • Table 648. United States Needle-free Injection Systems, by End User USD Million (2020-2025)
  • Table 649. Canada Needle-free Injection Systems, by Type USD Million (2020-2025)
  • Table 650. Canada Needle-free Injection Systems, by Application USD Million (2020-2025)
  • Table 651. Canada Needle-free Injection Systems, by Technology USD Million (2020-2025)
  • Table 652. Canada Needle-free Injection Systems, by Medication USD Million (2020-2025)
  • Table 653. Canada Needle-free Injection Systems, by Usability USD Million (2020-2025)
  • Table 654. Canada Needle-free Injection Systems, by Site of Delivery USD Million (2020-2025)
  • Table 655. Canada Needle-free Injection Systems, by End User USD Million (2020-2025)
  • Table 656. Mexico Needle-free Injection Systems, by Type USD Million (2020-2025)
  • Table 657. Mexico Needle-free Injection Systems, by Application USD Million (2020-2025)
  • Table 658. Mexico Needle-free Injection Systems, by Technology USD Million (2020-2025)
  • Table 659. Mexico Needle-free Injection Systems, by Medication USD Million (2020-2025)
  • Table 660. Mexico Needle-free Injection Systems, by Usability USD Million (2020-2025)
  • Table 661. Mexico Needle-free Injection Systems, by Site of Delivery USD Million (2020-2025)
  • Table 662. Mexico Needle-free Injection Systems, by End User USD Million (2020-2025)
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Needle-free Injection Systems: by Type USD Million (2014-2019)
  • Figure 5. Global Needle-free Injection Systems: by Application USD Million (2014-2019)
  • Figure 6. Global Needle-free Injection Systems: by Technology USD Million (2014-2019)
  • Figure 7. Global Needle-free Injection Systems: by Medication USD Million (2014-2019)
  • Figure 8. Global Needle-free Injection Systems: by Usability USD Million (2014-2019)
  • Figure 9. Global Needle-free Injection Systems: by Site of Delivery USD Million (2014-2019)
  • Figure 10. Global Needle-free Injection Systems: by End User USD Million (2014-2019)
  • Figure 11. South America Needle-free Injection Systems Share (%), by Country
  • Figure 12. Asia Pacific Needle-free Injection Systems Share (%), by Country
  • Figure 13. Europe Needle-free Injection Systems Share (%), by Country
  • Figure 14. MEA Needle-free Injection Systems Share (%), by Country
  • Figure 15. North America Needle-free Injection Systems Share (%), by Country
  • Figure 16. Global Needle-free Injection Systems: by Type K Units (2014-2019)
  • Figure 17. Global Needle-free Injection Systems: by Application K Units (2014-2019)
  • Figure 18. Global Needle-free Injection Systems: by Technology K Units (2014-2019)
  • Figure 19. Global Needle-free Injection Systems: by Medication K Units (2014-2019)
  • Figure 20. Global Needle-free Injection Systems: by Usability K Units (2014-2019)
  • Figure 21. Global Needle-free Injection Systems: by Site of Delivery K Units (2014-2019)
  • Figure 22. Global Needle-free Injection Systems: by End User K Units (2014-2019)
  • Figure 23. South America Needle-free Injection Systems Share (%), by Country
  • Figure 24. Asia Pacific Needle-free Injection Systems Share (%), by Country
  • Figure 25. Europe Needle-free Injection Systems Share (%), by Country
  • Figure 26. MEA Needle-free Injection Systems Share (%), by Country
  • Figure 27. North America Needle-free Injection Systems Share (%), by Country
  • Figure 28. Global Needle-free Injection Systems: by Type USD/Units (2014-2019)
  • Figure 29. Global Needle-free Injection Systems share by Players 2019 (%)
  • Figure 30. Global Needle-free Injection Systems share by Players (Top 3) 2019(%)
  • Figure 31. Global Needle-free Injection Systems share by Players (Top 5) 2019(%)
  • Figure 32. BCG Matrix for key Companies
  • Figure 33. BD Medical (United States) Revenue, Net Income and Gross profit
  • Figure 34. BD Medical (United States) Revenue: by Geography 2019
  • Figure 35. Medtronic(United States) Revenue, Net Income and Gross profit
  • Figure 36. Medtronic(United States) Revenue: by Geography 2019
  • Figure 37. Smiths Medical (United States) Revenue, Net Income and Gross profit
  • Figure 38. Smiths Medical (United States) Revenue: by Geography 2019
  • Figure 39. Antares Pharma Inc(United States) Revenue, Net Income and Gross profit
  • Figure 40. Antares Pharma Inc(United States) Revenue: by Geography 2019
  • Figure 41. Endo International(Ireland) Revenue, Net Income and Gross profit
  • Figure 42. Endo International(Ireland) Revenue: by Geography 2019
  • Figure 43. Pharma Jet (Netherlands) Revenue, Net Income and Gross profit
  • Figure 44. Pharma Jet (Netherlands) Revenue: by Geography 2019
  • Figure 45. Bioject Medical Technologies (United States) Revenue, Net Income and Gross profit
  • Figure 46. Bioject Medical Technologies (United States) Revenue: by Geography 2019
  • Figure 47. Terumo Corporation(Japan) Revenue, Net Income and Gross profit
  • Figure 48. Terumo Corporation(Japan) Revenue: by Geography 2019
  • Figure 49. Medical International Technology(Canada) Revenue, Net Income and Gross profit
  • Figure 50. Medical International Technology(Canada) Revenue: by Geography 2019
  • Figure 51. Injex Pharama Ag (Germany) Revenue, Net Income and Gross profit
  • Figure 52. Injex Pharama Ag (Germany) Revenue: by Geography 2019
  • Figure 53. Global Needle-free Injection Systems: by Type USD Million (2020-2025)
  • Figure 54. Global Needle-free Injection Systems: by Application USD Million (2020-2025)
  • Figure 55. Global Needle-free Injection Systems: by Technology USD Million (2020-2025)
  • Figure 56. Global Needle-free Injection Systems: by Medication USD Million (2020-2025)
  • Figure 57. Global Needle-free Injection Systems: by Usability USD Million (2020-2025)
  • Figure 58. Global Needle-free Injection Systems: by Site of Delivery USD Million (2020-2025)
  • Figure 59. Global Needle-free Injection Systems: by End User USD Million (2020-2025)
  • Figure 60. South America Needle-free Injection Systems Share (%), by Country
  • Figure 61. Asia Pacific Needle-free Injection Systems Share (%), by Country
  • Figure 62. Europe Needle-free Injection Systems Share (%), by Country
  • Figure 63. MEA Needle-free Injection Systems Share (%), by Country
  • Figure 64. North America Needle-free Injection Systems Share (%), by Country
  • Figure 65. Global Needle-free Injection Systems: by Type K Units (2020-2025)
  • Figure 66. Global Needle-free Injection Systems: by Application K Units (2020-2025)
  • Figure 67. Global Needle-free Injection Systems: by Technology K Units (2020-2025)
  • Figure 68. Global Needle-free Injection Systems: by Medication K Units (2020-2025)
  • Figure 69. Global Needle-free Injection Systems: by Usability K Units (2020-2025)
  • Figure 70. Global Needle-free Injection Systems: by Site of Delivery K Units (2020-2025)
  • Figure 71. Global Needle-free Injection Systems: by End User K Units (2020-2025)
  • Figure 72. South America Needle-free Injection Systems Share (%), by Country
  • Figure 73. Asia Pacific Needle-free Injection Systems Share (%), by Country
  • Figure 74. Europe Needle-free Injection Systems Share (%), by Country
  • Figure 75. MEA Needle-free Injection Systems Share (%), by Country
  • Figure 76. North America Needle-free Injection Systems Share (%), by Country
  • Figure 77. Global Needle-free Injection Systems: by Type USD/Units (2020-2025)
Some of the key companies/manufacturers profiled in the report
  • BD Medical (United States)
  • Medtronic(United States)
  • Smiths Medical (United States)
  • Antares Pharma Inc(United States)
  • Endo International(Ireland)
  • Pharma Jet (Netherlands)
  • Bioject Medical Technologies (United States)
  • Terumo Corporation(Japan)
  • Medical International Technology(Canada)
  • Injex Pharama Ag (Germany)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation